About the Authors

Remi Villenave

Contributed equally to this work with: Remi Villenave, Samantha Q. Wales, Tiama Hamkins-Indik

Current address: Emulate, Inc., Boston, Massachusetts

Affiliation Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts, United States of America

Samantha Q. Wales

Contributed equally to this work with: Remi Villenave, Samantha Q. Wales, Tiama Hamkins-Indik

Affiliation Molecular Virology Team, Division of Molecular Biology, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, Laurel, Maryland, United States of America

Tiama Hamkins-Indik

Contributed equally to this work with: Remi Villenave, Samantha Q. Wales, Tiama Hamkins-Indik

Affiliation Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts, United States of America

Efstathia Papafragkou

Affiliation Molecular Virology Team, Division of Molecular Biology, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, Laurel, Maryland, United States of America

James C. Weaver

Affiliation Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts, United States of America

Thomas C. Ferrante

Affiliation Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts, United States of America

Anthony Bahinski

Current address: GlaxoSmithKline, King of Prussia, Pennsylvania

Affiliation Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts, United States of America

Christopher A. Elkins

Affiliation Molecular Virology Team, Division of Molecular Biology, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, Laurel, Maryland, United States of America

Michael Kulka

Affiliation Molecular Virology Team, Division of Molecular Biology, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, Laurel, Maryland, United States of America

Donald E. Ingber

don.ingber@wyss.harvard.edu

Affiliations Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts, United States of America, Harvard John A. Paulson School of Engineering and Applied Sciences, Cambridge, Massachusetts, United States of America, Vascular Biology Program, Boston Children’s Hospital and Harvard Medical School, Boston, Massachusetts, United States of America

Competing Interests

D.E.I. holds equity in Emulate Inc. as founder and chairman of its Scientific Advisory Board. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceptualization: RV SQW CAE MK DEI. Funding acquisition: CAE MK DEI. Investigation: RV SQW THI EP JCW TCF MK. Methodology: RV SQW THI MK DEI. Project administration: AB CAE MK DEI. Writing – original draft: RV SQW MK DEI.